Taku Toyoshima Selected Research

Thrombosis (Thrombus)

1/2023	Angioscopic Evaluation of Vascular Response After Fluoropolymer-Based Drug-Eluting Stent Implantation for Femoropopliteal Artery Lesions.
1/2023	Identification of post-procedural optical coherence tomography findings associated with the 1-year vascular response evaluated by coronary angioscopy.
9/2022	Very Early Progression of an In-Stent Calcified Nodule 2 Weeks After Drug-Eluting Stent Implantation in the Calcified Lesion.
7/2022	Very late stent thrombosis caused by the rupture of in-stent neoatherosclerosis 15 years after bare nitinol stent implantation in superficial femoral artery visualized with multimodality imaging.
1/2022	Long-Term Outcomes and Clinical Predictors of Mortality Following Occurrence of Stent Thrombosis.
1/2022	Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome.
11/2021	Early- and Middle-Phase Angioscopic Assessment of Arterial Healing Following Current Drug-Eluting Stent Implantation in Patients With Acute Coronary Syndrome.
5/2021	Arterial Healing 10 Months After Implantation of an Ultrathin-Strut, Biodegradable-Polymer, Sirolimus-Eluting Stent　- An Angioscopic Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taku Toyoshima Research Topics

Disease

8	Thrombosis (Thrombus) 01/2023 - 05/2021
6	Chronic Limb-Threatening Ischemia 11/2023 - 09/2022
4	Atrial Fibrillation 01/2023 - 01/2022
3	Diabetes Mellitus 11/2023 - 07/2023
2	Infections 06/2024 - 01/2023
2	Pathologic Constriction (Stenosis) 06/2024 - 07/2021
2	Wounds and Injuries (Trauma) 08/2023 - 01/2023
2	Heart Failure 06/2023 - 01/2023
2	Ischemia 01/2023 - 03/2021
2	Neointima 01/2023 - 01/2023
2	Acute Coronary Syndrome 01/2022 - 11/2021
1	Embolism (Embolus) 08/2023
1	Hemorrhage 04/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Atrial Remodeling 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022
1	Peripheral Arterial Disease 09/2022
1	Rupture 07/2022
1	Myocardial Infarction 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022
1	Death (Near-Death Experience) 01/2022
1	Aneurysm (Aneurysms) 07/2021
1	Atherosclerotic Plaque (Atheroma) 07/2021
1	Intermittent Claudication 07/2021
1	Ulcer 03/2021

Drug/Important Bio-Agent (IBA)

1	Fluorocarbon PolymersIBA 06/2024
1	CholesterolIBA 08/2023
1	Atrial Natriuretic Factor (ANF)IBA 01/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023
1	nitinolIBA 07/2022
1	oxidized low density lipoproteinIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	LipidsIBA 01/2022

Therapy/Procedure

13	Stents 06/2024 - 03/2021
6	Renal Dialysis (Hemodialysis) 11/2023 - 09/2022
6	Therapeutics 10/2023 - 03/2021
5	Drug-Eluting Stents 06/2024 - 07/2021
3	Catheter Ablation 01/2023 - 01/2022
1	Surgical Amputation (Amputations) 04/2023